Key Takeaways:
- Jenscare Scientific is preparing to raise a reported $30 million in a Hong Kong IPO, even though it doesn’t expect to earn any product-related revenue until the latter half of next year at earliest
- The company’s valuation reached $1.36 billion last year, but could possibly dive by the time it debuts due to weak overall market sentiment
